Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.36 |
| ▸ | ACHE | P22303 | 9/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6276861 | 0.76 | — | — | |
| SCHEMBL6283384 | 0.74 | EPHX1 (0.31) | EPHX1ACHEMGLL | |
| SCHEMBL6315703 | 0.72 | DGAT1 (0.31) | — | |
| SCHEMBL6276781 | 0.69 | EPHX1 (0.39) | EPHX1ACHEMGLLZDHHC20ZDHHC2 | |
| SCHEMBL9576653 | 0.67 | EPHX1 (0.46) | EPHX1ACHEMGLLMMP2ZDHHC20 | |
| SCHEMBL1900050 | 0.66 | EPHX1 (0.44) | EPHX1ACHEMGLLMMP2ZDHHC20 | |
| SCHEMBL2736685 | 0.66 | EPHX1 (0.55) | EPHX1ACHEMMP2 | |
| SCHEMBL10765973 | 0.66 | EPHX1 (0.55) | EPHX1ACHEMMP2 | |
| SCHEMBL15355956 | 0.65 | EPHX1 (0.47) | EPHX1ACHEMMP2ZDHHC20ZDHHC2 | |
| SCHEMBL25848647 | 0.64 | EPHX1 (0.53) | EPHX1ACHEMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6841703-B2 | Open chain alkoxyamine compounds and their use as polymerization regulators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-01-11 | — | — | US | disclosed |
| EP-1100772-B1 | OPEN CHAIN ALKOXYAMINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS | CIBA SC HOLDING AG (CH) | 2004-04-14 | — | — | EP | disclosed |
| US-20030125489-A1 | Open chain alkoxyamine compounds and their use as polymerization regulators | NESVADBA PETER (CH) | 2003-07-03 | — | — | US | disclosed |
| US-6518326-B1 | Open chain alkoxyamine compounds and their use as polymerization regulators | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125489-A1 | Open chain alkoxyamine compounds and their use as polymerization regulators | ALOX5, PTGER1, ALOX12 | EPHX1 174/4885ACHE 3080/4885MGLL 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.